Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Recruiting 8Completed 5Terminated 3Unknown 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 2Lymphoma, B-Cell 1Leukemia 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Consolidation Chemotherapy × Clear all
NCT02927938 2022-04-21

Leukemia Stem Cell Detection in Acute Myeloid Leukemia

Wake Forest University Health Sciences

Phase 3 Terminated
18 enrolled 25 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01246752 2021-10-29

AML

University Hospital Carl Gustav Carus

Phase 3 Terminated
143 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00906841 2018-04-27

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

French Innovative Leukemia Organisation

Phase 2 Terminated
75 enrolled
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡